Skip to main navigation
Go back to homepage
  • About Us
    • Overview
    • Our Values
    • Leadership
    • Board of Directors
  • Focus
    • Overview
    • PAH & PH-ILD
    • Inhaled Treprostinil
  • Pipeline & Products
    • Our Pipeline
    • L606
    • Clinical Trials
    • Commercial Products
    • Publications
  • Technology
    • Overview
    • PRINT
  • Patients
  • Medical Professionals
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Analyst Coverage
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Corporate Governance
      • Documents & Charters
      • Leadership
      • Board of Directors
      • Committee Composition
    • SEC Filings
    • IR Resources
      • Investor FAQs
      • IR Contact
      • Email Alerts
      • Proxy Online
  • Careers
    • Overview
    • Our Values
    • Employee Benefits
    • Career Opportunities

Publications

Pioneers in rare cardiopulmonary disease

Explore the science behind our clinical trials.

Search

February 23, 2026
| Publication
Hall, S.
The Essential Role of Caregivers in Pulmonary Hypertension: A Patient Advocacy Perspective on Support, Resources, and the Unique Challenges Facing Families.
Respiratory Therapy Vol 21 No. 2 Spring 2026
January 31, 2026
| Poster
D. Lachant, A. Galloway, D. Fleming, R. Saggar, S. Patel, R. James White
Changes in Cardiac Effort in Pulmonary Hypertension-Interstitial Lung Disease: Insights from the ASCENT Trial
Dublin, Ireland
January 30, 2026
| Poster
R. Restrepo-Jaramillo, A. Muralidhar, M. Trivieri, C. Burger, J. Elwing, J. Feldman, S. Shapiro, J. Yau, P. Kan, A. Leblond, S. Khindri, R. Saggar
Open-label, Multicenter Study to Evaluate the Safety and Efficacy of Liposomal Treprostinil Inhalation Suspension (L606) in Subjects with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
Dublin, Ireland
January 29, 2026
| Poster
R. Saggar, A. Ravichandran, N. Kolaitis, A. Muralidhar, J. Feldman, M. Patricia George, R. Restrepo-Jaramillo, J. Ryan, S. Patel, A. Galloway, R. Saggar, J. White, V. McLaughlin
Safety and Exploratory Efficacy data of LIQ861 Dry Powder Inhaled Treprostinil in PH-ILD patients: ASCENT to Week 24
Dublin, Ireland
October 21, 2025
| Presentation
Kolaitis, N. A.
Safety and Exploratory Efficacy Data of LIQ861 DPI Treprostinil in PH-ILD: ASCENT to Week 16. CHEST Annual Meeting
Chicago, IL
October 21, 2025
| Presentation
Lachant, D., DO
Cardiac Effort in Pulmonary Hypertension-Interstitial Lung Disease: Insights from the ASCENT Trial. CHEST Annual Meeting.
Chicago, IL
September 19, 2025
| Poster
Stephen Sallee, Ashwin Ravichandran, Christy Ma, John Ryan, Marjorie P. George, Susanne McDevitt, Savan Patel, Ashley Galloway, Rajeev Saggar, Melisa Wilson
A Continued ASCENT to Week 8: Safety and Exploratory Efficacy Data on LIQ861 Dry Powder Inhaled Treprostinil in PH-ILD Patients
Seattle, WA
May 20, 2025
| Poster
Saggar, R., Ravichandran, A., Habib, N., Patel, S., Galloway, A., Saggar, R., Jeremy Feldman, J.
An ASCENT to Week 8: Initial Safety and Exploratory Efficacy Data on LIQ861 Dry Powder Inhaled Treprostinil in PH-ILD Patients
San Francisco, CA
May 20, 2025
| Poster
Lachant, D., Patel, S., Saggar, R., Galloway, A., White, R.J
Changes in Cardiac Effort in Pulmonary Hypertension-Interstitial Lung Disease: Insights From the ASCENT Trial
San Francisco, CA
May 20, 2025
| Poster
Flores, S.M., Patel, S., Estrada, R.
Transitioning From Parenteral Treprostinil to LIQ861 in a Patient With PAH
San Francisco, CA
  • Current page 1
  • Page 2
  • Page 3
  • …
  • Next page ›
  • Last page »
Go back to homepage

Socials

  • Science
    • Pipeline & Products
    • Technology
    • Publications
  • Company
    • About
    • Leadership
    • Board of Directors
    • Careers
    • Contact
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • Corporate Social Responsibility
    • Financial Information

Copyright © 2026 Liquidia Corporation. All Rights Reserved.

  • Accessibility
  • Cookie Policy
  • Legal
  • Privacy Policy